Employees Retirement System of Texas’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Employees Retirement System of Texas’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-172,165	Closed	-$654K	–	793
2020 Q1	$654K	Hold	172,165	–	–	0.01%	657
2019 Q4	$876K	Hold	172,165	–	–	0.01%	718
2019 Q3	$870K	Buy	172,165 +45,165	+36%	+$225K	0.01%	748
2019 Q2	$784K	Sell	127,000 -83,000	-40%	-$400K	0.01%	855
2019 Q1	$974K	Hold	210,000	–	–	0.01%	814
2018 Q4	$882K	Hold	210,000	–	–	0.01%	826
2018 Q3	$1.32M	Buy	210,000 +71,000	+51%	+$545K	0.02%	768
2018 Q2	$1.12M	Buy	139,000 +25,000	+22%	+$191K	0.02%	822
2018 Q1	$850K	Hold	114,000	–	–	0.01%	856
2017 Q4	$678K	Hold	114,000	–	–	0.01%	919
2017 Q3	$839K	Buy	114,000 +32,000	+39%	+$203K	0.01%	856
2017 Q2	$557K	Buy	+82,000	New	+$605K	0.01%	933

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Employees Retirement System of Texas's PGNX Position: Q2 2020 in Review

Employees Retirement System of Texas sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 172,165 shares — an estimated $654K sold.

Employees Retirement System of Texas first reported a position in PGNX in Q2 2017 and held it in 12 quarters. The position peaked at $1.32M in Q3 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Employees Retirement System of Texas reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Employees Retirement System of Texas sold 172,165 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $654K.
Employees Retirement System of Texas first reported a position in Progenics Pharmaceuticals Inc in Q2 2017 and held it in 12 quarters.
Employees Retirement System of Texas's Progenics Pharmaceuticals Inc position peaked at $1.32M in Q3 2018.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Employees Retirement System of Texas's 13F filing for Q2 2020, filed 12 Aug 2020.